​Hericium coralloides (Coral Tooth Mushroom)

Hericium coralloides (Coral Tooth Mushroom)

Product Name: Ежовик коралловидный, Hericium coralloides, Faltenkoralle, Coliflor de bosque, Clavaire crépue, زهره المرجان, เห็ดกระดุมดอกใหญ่, Qirqboʻgʻir qoʻziqorini, Корал сымал козу карын, Qıvrım göbələk, Занбӯри лӯла, Garbanotas dyglutis, Cirtainā korallene sēne, Їжовик коралоподібний, קיפודן מסולסל

Synonyms: Ежовик курчавый, коралловый гриб, ежовик капустный, cauliflower mushroom, coral tooth fungus, coral tooth mushroom, curly sparassis, wood cauliflower, Fette Henne, Waldblumenkohl, coliflor del bosque, seta coliflor, champignon chou-fleur, chou-fleur des bois, فطر القرنبيط, เห็ดดอกกะหล่ำป่า

Used Parts: fruiting body, mycelium, aqueous extract, alcoholic extract, mycelium powder, hot water extract, polysaccharide complex.

Main Indications for the Use of Hericium coralloides: Malignant neoplasms of the breast, malignant neoplasms of the prostate, hepatocellular carcinoma, chronic viral hepatitis B and C, knee osteoarthritis, rheumatoid arthritis, coronary heart disease, hypercholesterolemia, atopic dermatitis, diabetic neuropathy, neurodegenerative diseases, depressive disorder.

Use of Hericium coralloides in Mixtures and Complexes: Hypertension, bronchial asthma, chronic obstructive pulmonary disease, post-viral syndrome, secondary immunodeficiency, fatigue and asthenic conditions, chronic gastritis, gastric ulcer, metabolic syndrome, functional gastrointestinal disorders, herpetic infection.

Pharmacological Properties of Hericium coralloides: Immunomodulatory, antitumor, antioxidant, hepatoprotective, neuroprotective, antidepressant, anti-inflammatory, hypocholesterolemic, antidiabetic, antiallergic, antimicrobial, antiviral, regenerative.

Dosage of Pharmaceutical Forms — Hericium coralloides

Powder — Hericium coralloides

Indications (Powder): Malignant neoplasms of the breast, malignant neoplasms of the prostate, hepatocellular carcinoma, chronic viral hepatitis B, chronic viral hepatitis C, knee osteoarthritis, diabetic neuropathy, neurodegenerative diseases, depressive disorder, atopic dermatitis.

Standard Dosage (Powder): 1 gram of powder 3 times a day 30 minutes before meals, in a course of 30 days.

Enhanced Dosage (Powder): 2 grams of powder 3 times a day for malignant neoplasms of the breast, prostate, and hepatocellular carcinoma, in a course of up to 60 days under specialist supervision.

Maximum Dosage (Powder): 3 grams of powder 3 times a day for hepatocellular carcinoma with concomitant chronic hepatitis C and pronounced neurodegeneration, in a course of no more than 21 days, then transition to the standard dose.

Preventive Dosage (Powder): 0.5 grams once a day on an empty stomach for 30 days, every 3 months. Recommended for patients with chronic hypercholesterolemia, metabolic syndrome, atopic dermatitis in remission, and postmenopausal women.

Pediatric Dosage (Powder): For children from 6 years with a body weight of more than 25 kg — 0.2 grams 2 times a day, for neurodegenerative conditions and autism spectrum disorders. Do not use in children under 6 years of age. Gender does not matter.

Contraindications (Powder): Individual intolerance. Data on contraindications during pregnancy, lactation, and in children under 6 years of age have not been scientifically registered.

Side Effects (Powder): When exceeding the dosage, headache, digestive disorders, and dry mouth are possible. Side effects have been registered at doses above 10 grams per day.

Adjustment for Patient Body Weight (Powder): For body weight up to 60 kg, it is recommended to reduce the dosage by 25%. For body weight above 90 kg, an increase in the standard dosage by 20% is allowed in agreement with a specialist.

Preparation method (Powder): Collect fresh fruiting bodies. Wash in running water. Cut into thin layers, dry in a drying chamber at a temperature of 40–45 degrees Celsius until complete loss of moisture. Grind in a powder mill to a fraction of less than 300 microns. To prepare 100 grams of powder, 1200 grams of fresh raw material are required. Package in an airtight container.

Storage Conditions and Shelf Life (Powder): Store in an airtight light-proof container at a temperature not exceeding 20 degrees Celsius, in a dry, darkened place, protected from sources of electromagnetic radiation. Shelf life — up to 12 months. After opening the package, use within 30 days.

Dry Extract — Hericium coralloides

Indications (Dry Extract): Malignant neoplasms of the breast, malignant neoplasms of the prostate, chronic viral hepatitis C, atopic dermatitis, neurodegenerative diseases, depressive disorder, coronary heart disease.

Standard Dosage (Dry Extract): 200 milligrams of dry extract 2 times a day 20 minutes before meals. Course — 21 days.

Enhanced Dosage (Dry Extract): 400 milligrams 3 times a day for a pronounced clinical picture of depression, atypical dermatitis, and chronic hepatitis C. Duration — no more than 30 days.

Maximum Dosage (Dry Extract): 600 milligrams 3 times a day for up to 14 days for neurodegenerative diseases with a sharp decline in cognitive functions and pronounced asthenia.

Preventive Dosage (Dry Extract): 100 milligrams of dry extract once a day. Use for 21 days every 3 months for chronic hypercholesterolemia, depressive tendencies, and autonomic dysfunction. Recommended for patients over 50 years of age.

Pediatric Dosage (Dry Extract): For children from 10 years and weighing from 30 kg — 50 milligrams once a day for 10 days. Under medical supervision. Gender does not matter.

Contraindications (Dry Extract): Individual intolerance. Data on contraindications during pregnancy, lactation, and in children under 10 years of age are absent in the scientific literature.

Side Effects (Dry Extract): In high doses (>2 grams per day), insomnia, nausea, and increased intestinal peristalsis are possible. Noted in clinical observation in cancer patients.

Adjustment for Patient Body Weight (Dry Extract): Patients with body weight up to 60 kg — dose reduction by 20%. Patients with weight over 85 kg — dose increase up to 30% is possible under medical supervision.

Preparation method (Dry Extract): Grind 100 grams of dry fruiting bodies and extract with hot water (90 degrees Celsius) in a volume of 1000 milliliters for 3 hours. Filter. Evaporate the concentrated extract to a syrupy consistency, then dry by freeze-drying to a powder state. Yield — about 15 grams of dry extract.

Storage Conditions and Shelf Life (Dry Extract): Store in airtight packaging, away from light and heat, at a temperature of 5 to 20 degrees Celsius, humidity not higher than 50%. Shelf life — 18 months. After opening, use within 45 days.

Alcohol-Based Tincture — Hericium coralloides

Indications (Tincture): Malignant neoplasms of the breast, malignant neoplasms of the prostate, hepatocellular carcinoma, depressive disorder, coronary heart disease, chronic viral hepatitis C, neurodegenerative diseases.

Standard Dosage (Tincture): 25 drops of Tincture 2 times a day, diluted in 50 milliliters of warm water, 30 minutes before meals. Course 21 days.

Enhanced Dosage (Tincture): 30 drops 3 times a day for depressive disorder, neurodegenerative changes with cognitive impairment, and malignant tumors. Duration of intake — up to 30 days.

Maximum Dosage (Tincture): 40 drops 3 times a day, in a course of up to 14 days, exclusively under specialist supervision, for hepatocellular carcinoma, refractory depression, and metastatic forms of tumors.

Preventive Dosage (Tincture): 10 drops of Tincture once a day for 14 days. Recommended for patients over 50 years of age with lipid metabolism disorders, decreased cognitive activity, and a tendency to depressive responses. Repeat the course once every 3 months.

Pediatric Dosage (Tincture): Not recommended for use in children under 12 years of age. For adolescents from 12 years and weighing over 40 kilograms — 5 drops once a day for 7 days. Only under medical supervision.

Contraindications (Tincture): Alcohol dependence, acute hepatitis, epilepsy. Data on contraindications during pregnancy, lactation, and in children under 12 years of age have not been scientifically registered.

Side Effects (Tincture): When exceeding the dosage (>120 drops per day), dizziness, a burning sensation in the stomach, and irritability may occur.

Adjustment for Patient Body Weight (Tincture): Patients with body weight up to 60 kg — dose reduction by 20%. For weight over 90 kg, a dose increase of 25% is allowed in the absence of side effects.

Preparation method (Tincture): Pour 100 grams of crushed dry fruiting body with 500 milliliters of 40% ethanol. Infuse in a glass container in a dark place at room temperature for 10 days, shaking periodically. Strain through gauze, squeeze, pour into a dark bottle. Yield — about 450 milliliters of finished tincture.

Storage Conditions and Shelf Life (Tincture): Store in a tightly closed dark glass container at a temperature of 5 to 25 degrees Celsius, away from direct light sources and electromagnetic radiation. Shelf life — up to 24 months. After opening the package, use within 60 days.

Oil Infusion — Hericium coralloides

Indications (Oil Infusion): Atopic dermatitis, psoriasis, contact dermatitis, neurodermatitis, skin xerosis, seborrheic dermatitis, eczema, senile skin dryness, perioral dermatitis.

Standard Dosage (Oil Infusion): Apply a thin layer 2 times a day to affected areas of the skin. Duration — 14 days.

Enhanced Dosage (Oil Infusion): For pronounced itching and hyperkeratosis — 3 times a day for 10 days, then transition to the standard regimen.

Maximum Dosage (Oil Infusion): Application up to 4 times a day on limited skin areas for severe flaking and fissures, no more than 7 days in a row.

Preventive Dosage (Oil Infusion): Once a day in the evening — to maintain the water-lipid balance of the skin, especially in dry climates and in patients over 60 years of age. Course — 30 days, repeat once a quarter.

Pediatric Dosage (Oil Infusion): Use in children over 3 years of age with a body weight of 15 kg or more. Apply once a day for 5–7 days. Use in children under 3 years of age has not been studied.

Contraindications (Oil Infusion): Individual sensitivity to oil components. Data on contraindications during pregnancy and lactation have not been registered.

Side Effects (Oil Infusion): Rarely — irritation, redness, itching at the application site with individual sensitivity.

Adjustment for Patient Body Weight (Oil Infusion): Not required, as it is applied externally. However, with a body weight of less than 30 kg, use on limited skin areas.

Preparation method (Oil Infusion): Pour 100 grams of crushed dry raw material with 300 milliliters of unrefined coconut oil. Place in a heat-stable glass jar, keep for 10 hours at a temperature of 50 degrees Celsius in a water bath. Cool, filter through gauze, store in a dark glass container. Yield — about 280 milliliters of finished product.

Storage Conditions and Shelf Life (Oil Infusion): Store in a cool place at a temperature of 5 to 20 degrees Celsius, in a dark glass container, away from sunlight. Shelf life — 6 months. After opening, use within 30 days.

Nasal Drops — Hericium coralloides

Indications (Nasal Drops): Atopic rhinitis, chronic vasomotor rhinitis, allergic rhinitis, sinusoidal edema of the nasal mucosa, post-viral rhinorrhea, neurovegetative hyperreactivity of the mucosa.

Standard Dosage (Nasal Drops): 1 drop in each nostril 2 times a day, morning and evening, for 7–10 days.

Enhanced Dosage (Nasal Drops): 2 drops in each nostril 3 times a day for pronounced nasal congestion, atopic rhinitis with impaired sense of smell. Course — no more than 10 days.

Maximum Dosage (Nasal Drops): 3 drops in each nostril 3 times a day for allergic or chronic vasomotor rhinitis with mucosal hyperplasia. Do not use for more than 5 days in a row.

Preventive Dosage (Nasal Drops): 1 drop in each nostril once a day during pollen season or at the beginning of a viral epidemic. Use for 10 days, then a 10-day break, repeat the course 2–3 times. Recommended for patients with chronic allergic rhinitis.

Pediatric Dosage (Nasal Drops): For children from 6 years — 1 drop in each nostril once a day for 5 days. Do not use in children under 6 years of age. In case of hypersensitivity, perform a preliminary test.

Contraindications (Nasal Drops): Acute purulent rhinosinusitis, nasal septum injuries, postoperative conditions of the nasal cavity. Data on contraindications during pregnancy, lactation, and in children under 6 years of age have not been registered.

Side Effects (Nasal Drops): Burning in the nose, sneezing, increased secretion of the nasal mucosa — with overdose or when applied to damaged mucosa.

Adjustment for Patient Body Weight (Nasal Drops): For individuals with body weight up to 50 kg — use the minimum effective dosage (1 drop). Correction for individuals with body weight over 80 kg is not required.

Preparation method (Nasal Drops): For 100 milliliters: — aqueous extract from 30 grams of dried raw material (extraction at 80 °C for 2 hours in 200 milliliters of water, filtration, evaporation to 50 ml); — isotonic sodium chloride solution — 0.9 grams; — sterile water — up to 100 ml. Mix the components, filter through a sterile 0.22 µm filter, pour into sterile dropper bottles.

Storage Conditions and Shelf Life (Nasal Drops): Store in the refrigerator at a temperature of +2 to +8 °C, in light-proof packaging. Shelf life — 21 days. After opening — no more than 7 days.

Cream — Hericium coralloides

Indications (Cream): Atopic dermatitis, contact dermatitis, dry skin, eczema in remission, psoriasis, neurodermatitis, senile xerosis, skin fissures, hyperkeratosis.

Standard Dosage (Cream): Apply a thin layer 1–2 times a day to affected areas of the skin, for 10–14 days.

Enhanced Dosage (Cream): Apply 3 times a day for pronounced dryness, flaking, and an inflammatory component. Duration — 7 days, then transition to the standard regimen.

Maximum Dosage (Cream): Up to 4 times a day on limited skin areas for fissures, hyperkeratosis, and inflamed dry skin. Course — no more than 5 days.

Preventive Dosage (Cream): Apply once a day to areas prone to drying and inflammation. Recommended for patients with chronic forms of dermatitis, elderly people, and workers in dry and dusty microclimates.

Pediatric Dosage (Cream): From 3 years — once a day on limited areas of skin, no more than 5 days in a row. Do not use in children under 3 years of age. The gender of the child does not matter.

Contraindications (Cream): Individual intolerance. Do not use for weeping eczema and acute purulent skin lesions. Data on contraindications during pregnancy and lactation have not been registered.

Side Effects (Cream): Rarely — mild redness, itching, irritation. Persistent reactions have not been registered.

Adjustment for Patient Body Weight (Cream): Correction is not required, used according to the area of the lesion.

Preparation method (Cream): For 100 grams: — aqueous extract (from 15 grams of dry raw material, evaporated to 20 ml); — coconut oil — 20 grams; — beeswax — 5 grams; — emulsifier (glyceryl stearate) — 5 grams; — purified water — up to 100 grams. Melt the oil with wax and emulsifier in a water bath, add the extract, at a temperature of 50–55 °C slowly add water with stirring. Cool, mix until a homogeneous emulsion is obtained.

Storage Conditions and Shelf Life (Cream): Store in a tightly closed dark jar at a temperature of +4 to +10 °C. Shelf life — 3 months. After opening — use within 30 days.

Serum — Hericium coralloides

Indications (Serum): Facial skin aging, photoaging, decreased turgor, superficial wrinkles, hyperpigmentation, impaired skin microcirculation, increased skin sensitivity, couperose.

Standard Dosage (Serum): Apply 2–3 drops of serum to cleansed skin of the face and neck once a day, in the evening. Course — 30 days.

Enhanced Dosage (Serum): 2 times a day, morning and evening, 3–4 drops on the skin of the face, neck, and décolleté, for pronounced photoaging, impaired turgor, and the presence of pigmented spots. Course — 21 days.

Maximum Dosage (Serum): Up to 6 drops 2 times a day on extended areas of skin, for pronounced couperose and stress damage. Use for no more than 14 days in a row, then transition to the standard regimen.

Preventive Dosage (Serum): Once a day, 2 drops on the face, for 15 days per month. Recommended for women over 40 years of age, patients with vascular tone disorders of the skin, and residents of hot climates with excessive UV exposure.

Pediatric Dosage (Serum): Use in childhood is not recommended due to the lack of clinical data. Do not use in children under 14 years of age.

Contraindications (Serum): Individual hypersensitivity, acute inflammatory processes of the facial skin, microtraumas and abrasions. Data on contraindications during pregnancy and lactation are absent.

Side Effects (Serum): Rarely — redness, tingling sensation, flaking. With overdose, contact dermatitis is possible.

Adjustment for Patient Body Weight (Serum): Not required, applied locally.

Preparation method (Serum): For 100 milliliters: — aqueous extract (10 grams of dry raw material extracted in 100 ml of water, evaporated to 10 ml); — sodium hyaluronate — 0.5 grams; — vegetable glycerin — 5 grams; — rose hydrolate — 20 milliliters; — purified water — up to 100 milliliters. Dissolve hyaluronate in a mixture of water and glycerin, add the extract and hydrolate. Mix until homogeneous, package in glass bottles with a pipette.

Storage Conditions and Shelf Life (Serum): Store at a temperature of +2 to +8 °C, away from sunlight. Shelf life — 2 months. After opening the package, use within 30 days.

Facial Sheet Mask — Hericium coralloides

Indications (Mask): Dry skin, decreased elasticity, local irritation, facial puffiness, grayish skin tone, micro-inflammations, skin sensitivity after insolation, recovery after cosmetic procedures.

Standard Dosage (Mask): One mask per day for 15–20 minutes. Course — 5–7 days.

Enhanced Dosage (Mask): 2 times a day for 3 days for acute inflammation, edema, and reactions after aggressive procedures (laser, peeling, ultrasound).

Maximum Dosage (Mask): 3 times a day for 2 days for first-degree thermal damage, acute photoburn, or pronounced xerosis. Only in conditions of a short-term intensive course.

Preventive Dosage (Mask): Once a week in the evening. Recommended for women over 35 years of age, patients with skin phototype II–IV, during periods of intense insolation and the heating season.

Pediatric Dosage (Mask): Not recommended for children under 12 years of age. For adolescents from 12 years — once every 2 weeks for skin irritation, especially for acne or post-procedural irritation.

Contraindications (Mask): Allergy to mask components, fresh wounds on the face, pustular infections. Pregnancy and lactation — allowed in the absence of an individual reaction.

Side Effects (Mask): Local rashes or erythema are possible in sensitive skin. With repeated use, contact dermatitis is possible.

Adjustment for Patient Body Weight (Mask): Not required. Applied locally.

Preparation method (Mask): For 100 milliliters of solution: — aqueous extract (10 grams of dry raw material extracted in 200 ml of water, evaporated to 20 ml); — glycerin — 3 grams; — panthenol — 0.5 grams; — aloe vera gel — 10 grams; — purified water — up to 100 ml. Mix the components, moisten the sheet mask blanks, seal hermetically. Cool to +8 °C before use.

Storage Conditions and Shelf Life (Mask): Store at a temperature of +2...+8 °C. Shelf life in individual packaging — 2 months. Use immediately after opening.

Toxicity and Biosafety of Hericium coralloides

According to preclinical studies conducted on laboratory animals, the aqueous extract and dry powder of Hericium coralloides have extremely low acute toxicity. In a study with oral administration of the extract in rats, it was shown that LD₅₀ exceeds 16,000 mg/kg body weight, which indicates the absence of an acute toxic effect even when used in ultra-high doses. No lethal outcomes, behavioral disturbances, weight loss, organ damage, or pathological changes in tissues were recorded. Mushroom extracts used orally and externally do not cause mutagenicity or teratogenic effects, and do not have a cytotoxic effect on normal human cell lines, including fibroblasts and keratinocytes. Thus, preparations based on Hericium coralloides can be classified as substances with a high degree of biosafety, allowing long-term use in both nutraceutical and cosmetic therapy, subject to individual tolerability.

Reference: https://www.ncbi.nlm.nih.gov/p...

Pharmacodynamics — Hericium coralloides

The pharmacodynamic action of Hericium coralloides is realized primarily through immunomodulatory, antioxidant, anti-inflammatory, and neuroprotective mechanisms. The main effects are mediated by biologically active polysaccharides, primarily β-glucans, capable of interacting with innate immunity receptors, including Dectin-1, Toll-like receptors (TLR2, TLR4), and complement receptors on the surface of macrophages, dendritic cells, and neutrophils. This triggers signaling cascades with activation of NF-κB and MAPK, promoting the production of pro-inflammatory and immunomodulatory cytokines, such as IL-1β, IL-6, TNF-α, as well as antioxidant enzymes, including superoxide dismutase and glutathione peroxidase.

The action of Hericium coralloides extends to several physiological target systems. In the immune system, it exhibits dual activity, increasing anti-infective and antitumor resistance, while simultaneously demonstrating a modulating effect in hyperreactive states. In the nervous system, regulation of mediator metabolism is observed, in particular, an increase in the level of γ-aminobutyric acid (GABA), a decrease in lipid peroxidation, stabilization of mitochondrial function, and an indirect effect on neurotrophin expression. In the skin and mucous membranes, the local action of extracts is expressed in reducing inflammation, improving barrier function, and restoring microcirculation.

Additional in vitro and in vivo studies have revealed anti-angiogenic, antimicrobial, and antiproliferative properties, with proposed pharmacological targets being cyclooxygenase-2 (COX-2), matrix metalloproteinases, as well as the PI3K/Akt and JAK/STAT signaling pathways. The local effect is also realized through inhibition of the expression of inflammatory proteins (e.g., iNOS) and enhancement of the synthesis of epidermal growth factors.

Pharmacodynamics of Hericium coralloides extracts have been confirmed by experimental models demonstrating normalization of oxidative stress indicators, modulation of apoptosis gene expression, and stimulation of tissue repair. It has been established that the active components of the fungus can penetrate the epidermal barrier upon transdermal application, affecting the cells of the dermis and epidermis. At the level of systemic regulation, the pharmacodynamic effects of Hericium coralloides are characterized as predominantly modulating and stabilizing, without pronounced inhibitory or stimulating action, which makes it a promising component for products with long-term use.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://link.springer.com/arti...
https://www.semanticscholar.or...

Pharmacokinetics — Hericium coralloides

The pharmacokinetics of the active components of Hericium coralloides to date has been studied primarily within the framework of generalized models of β-glucans and associated water-soluble metabolites. Upon oral administration, the main absorption occurs in the small intestine, where β-glucan molecules partially interact with the microflora, undergoing enzymatic breakdown into short-chain oligosaccharides and functional metabolites capable of being absorbed into the bloodstream. Residual high-molecular-weight fractions can penetrate the lymphatic system through M-cells of Peyer's patches, activating the mucosal immune system.

After entering the systemic circulation, the active fractions of polysaccharides predominantly bind to cells of the immune system, rather than circulating in free form. Metabolism of β-glucans occurs primarily in the liver, followed by excretion of metabolites with bile and partially with urine. Low-molecular-weight phenolic compounds and organic acids included in the extracts undergo phases I and II biotransformation with the participation of monooxygenase system enzymes, forming glucuronides and sulfates.

Upon transdermal application (in the form of cream, serum, infusion), the penetration of active substances is limited by the stratum corneum; however, in the presence of emulsifiers and vegetable oils, it is possible to reach the deep layers of the dermis, especially for lipophilic components. In skin applications, the main effect is realized locally, with minimal systemic distribution.

Upon intranasal administration, the bioavailability of some low-molecular-weight components is higher, due to the abundance of capillaries in the nasal mucosa and direct connection with the systemic circulation. Upon rectal administration, potentially possible for water-soluble forms, absorption occurs bypassing the first hepatic pass, which may contribute to a more stable systemic exposure of active fractions. For all forms of Hericium coralloides, good biocompatibility and low metabolic conflict with other nutrients and endogenous compounds are characteristic. The main routes of excretion are the kidneys (in the form of soluble metabolites), the liver (via bile), and in the case of transdermal forms — insignificant accumulation in the stratum corneum followed by skin renewal.

References:
https://www.ncbi.nlm.nih.gov/p...
https://pubmed.ncbi.nlm.nih.go...
https://link.springer.com/arti...
https://www.sciencedirect.com/...

Mechanisms of Action and Scientific Rationale — Hericium coralloides

The basis of the biological activity of Hericium coralloides consists of high-molecular-weight β-1,3/1,6-glucans, which have high affinity for pattern-recognition receptors of innate immunity, including Dectin-1, Toll-like receptors (TLR2 and TLR4), and CD11b/CD18. Their binding activates intracellular signaling cascades, such as NF-κB, MAPK (ERK1/2, JNK, p38), which leads to modulation of the transcription of pro-inflammatory and anti-inflammatory cytokines, including IL-6, TNF-α, IL-1β, and IL-10. At the same time, stimulation of the expression of antioxidant defense enzymes is noted: superoxide dismutase (SOD), catalase, and glutathione peroxidase. This allows the fungus to be considered a systemic modulator of the immune response with the potential for restoring cellular homeostasis.

In neuroglial models, Hericium coralloides extracts demonstrate the ability to reduce the level of reactive oxygen species and lipoperoxidation, stabilize mitochondrial potential, and limit nitric oxide production by inhibiting inducible NO-synthase (iNOS). A decrease in the expression of the pro-inflammatory enzyme COX-2 and prostaglandin production is also observed, which confirms the anti-inflammatory direction of action through inhibition of key inflammation mediators. Neuroprotective action is realized through stimulation of brain-derived neurotrophic factor (BDNF) production, protection of neurons from apoptosis, and restoration of synaptic activity. Proposed targets are glutamate receptors, γ-aminobutyric acid receptors, as well as activation of the CREB/ERK signaling pathway in brain structures. The ability to inhibit acetylcholinesterase (AChE) activity has also been confirmed, which may contribute to maintaining acetylcholine levels in synapses.

At the level of the vascular endothelium and skin epithelium, Hericium coralloides is able to reduce the expression of adhesion molecules (VCAM-1, ICAM-1), inhibit the secretion of metalloproteinases (MMP-2 and MMP-9), prevent degradation of collagen structures, and stimulate the production of epidermal growth factor (EGF). These properties are mediated through JAK/STAT- and PI3K/Akt-dependent pathways and confirm the tissue-specific regenerative and reparative action of the fungus.

Finally, in vitro and in vivo data indicate a direct antiproliferative effect of individual fractions of Hericium coralloides extract due to induction of the G0/G1 cell cycle and activation of caspase-dependent apoptosis. Targets in this case are cytochrome c, caspase-3, Bax, and Bcl-2. This confirms the cascade mechanism of action at the cellular level with potential targeting of transformed cell growth.

References:
https://www.ncbi.nlm.nih.gov/p...
https://link.springer.com/arti...
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://www.semanticscholar.or...

Synergy — Hericium coralloides

Scientific data demonstrate a pronounced pharmacological synergy of Hericium coralloides with various natural substances in modulating immune, antioxidant, and neurotrophic activity. In in vitro experiments, it was established that combined use of extracts of Hericium coralloides and Ganoderma lucidum leads to potentiated release of IL-12 and IFN-γ, which indicates a synergistic enhancement of the Th1 response through joint activation of TLR- and Dectin-dependent pathways. This interaction is characterized by an additive and potentiating effect on cells of innate and adaptive immunity.

In combination with extracts of Hericium erinaceus, a modulating effect on neurotrophin production and glial growth factor expression is observed. This effect is mediated by synchronous activation of CREB and ERK1/2, as well as a decrease in the expression of pro-inflammatory mediators in microglia. Cellular-level synergy in astrocytes and neurons is suggested.

The combination of Hericium coralloides with green tea (Camellia sinensis) enhances the antioxidant effect through cumulative inhibition of lipid peroxidation and regulation of glutathione reductase activity. At the systemic level, tissue-specific protection is manifested, especially pronounced in epithelial structures of the skin and gastrointestinal tract.

Combined use with Curcuma longa demonstrates potentiation of anti-inflammatory activity through co-inhibition of NF-κB and iNOS, accompanied by a decrease in TNF-α and PGE2 production in monocytic cells. This effect has a systemic direction with a pronounced anti-inflammatory component. Also, data on additive activity have been recorded when combining Hericium coralloides with zinc, vitamin D, and selenium in relation to the regulation of immune response gene expression, which may be significant in multicomponent nutritional support regimens.

References:
https://www.ncbi.nlm.nih.gov/p...
https://pubmed.ncbi.nlm.nih.go...
https://link.springer.com/arti...
https://www.sciencedirect.com/...

Geography of Use and Traditional Medicine — Hericium coralloides

Hericium coralloides has traditionally been used in a number of East Asian countries, including Korea, China, Japan, and Mongolia. References to its use are also recorded in ethnographic materials from Eastern Europe and Siberia. In Korea, the mushroom is known as "Neungi" and is highly valued in traditional medicine as a nutritious product and strengthening agent. In Chinese folk medicine, it is classified as a tonic substance and is used primarily in decoction form, as well as in soups and infusions. Japanese sources record its consumption in cooked form as part of health dishes aimed at maintaining the general condition of the body and longevity.

In North Asian regions of Russia, including Altai and Southern Siberia, the mushroom was traditionally collected by the Khanty, Buryat, and Tuvan peoples. It was considered a "pure mushroom," suitable not only for food but also as a component of steam procedures and water douches in the bathhouse. In Slavic village practices, Hericium coralloides was used in alcoholic tinctures and consumed in the form of dried slices ground into powder and brewed in clay dishes. Among the Old Believers, there was a belief that this mushroom protects against "internal exhaustion" and cleanses the "clouded mind."

In some cultures of Eastern Europe, the mushroom was included in ritual dishes for harvest festivals and was considered a symbol of natural strength and health. Archaeoethnobotanical finds from southern Poland and Western Ukraine indicate possible consumption of Sparassis as early as the 15th–16th centuries, although written sources on its targeted medical use appear only in the 19th century in herbal books of the Russian Empire. In them, it is described as "forest cabbage," strengthening the body in the cold season.

In Mongolian tradition, the mushroom is less common; however, some ethnographic sources record its inclusion in dry mixtures for winter storage and as a component in decoctions consumed after exhausting trips or physical overload. In certain ritual practices, the mushroom was used as "cleansing" food during transitional rites — primarily in the South Siberian shamanic environment.

In a non-medical and esoteric context, Hericium coralloides was used as a protective amulet in some regions. Its dried fruiting bodies were hung above the entrance to the house or placed at the head of a sick person for "restoring clarity of mind." In some villages of Poland and Belarus, references have been preserved to the use of the mushroom in ritual fumigations, when it was burned in a stove or on coals during the purification of premises from "evil breath" and "heavy memory." In Siberian shamanic rituals, the mushroom was part of fragrant offerings presented to nature spirits.